FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783142536> ?p ?o ?g. }

• W2783142536 abstract "Malignant cells have the capacity to rapidly grow exponentially and spread in part by suppressing, evading, and exploiting the host immune system. Immunotherapy is a form of oncologic treatment directed towards enhancing the host immune system against cancer. In recent years, manipulation of immune checkpoints or pathways has emerged as an important and effective form of immunotherapy. Agents that target cytotoxic T lymphocyte-associated molecule-4 (CTLA-4), programmed cell death receptor-1 (PD-1), and programmed cell death ligand-1 (PD-L1) are the most widely studied and recognized. Immunotherapy, however, extends beyond immune checkpoint therapy by using new molecules such as chimeric monoclonal antibodies and antibody drug conjugates that target malignant cells and promote their destruction. Genetically modified T cells expressing chimeric antigen receptors are able to recognize specific antigens on cancer cells and subsequently activate the immune system. Native or genetically modified viruses with oncolytic activity are of great interest as, besides destroying malignant cells, they can increase anti-tumor activity in response to the release of new antigens and danger signals as a result of infection and tumor cell lysis. Vaccines are also being explored, either in the form of autologous or allogenic tumor peptide antigens, genetically modified dendritic cells that express tumor peptides, or even in the use of RNA, DNA, bacteria, or virus as vectors of specific tumor markers. Most of these agents are yet under development, but they promise to be important options to boost the host immune system to control and eliminate malignancy. In this review, we have provided detailed discussion of different forms of immunotherapy agents other than checkpoint-modifying drugs. The specific focus of this manuscript is to include first-in-human phase I and phase I/II clinical trials intended to allow the identification of those drugs that most likely will continue to develop and possibly join the immunotherapeutic arsenal in a near future." @default.
• W2783142536 created "2018-01-26" @default.
• W2783142536 creator A5014209331 @default.
• W2783142536 creator A5023939060 @default.
• W2783142536 creator A5031005364 @default.
• W2783142536 creator A5034847496 @default.
• W2783142536 creator A5055922112 @default.
• W2783142536 date "2018-01-12" @default.
• W2783142536 modified "2023-10-15" @default.
• W2783142536 title "Cancer immunotherapy beyond immune checkpoint inhibitors" @default.
• W2783142536 cites W1532689189 @default.
• W2783142536 cites W1895049594 @default.
• W2783142536 cites W1913328895 @default.
• W2783142536 cites W1969342260 @default.
• W2783142536 cites W1973177425 @default.
• W2783142536 cites W1975895312 @default.
• W2783142536 cites W2011458181 @default.
• W2783142536 cites W2016795009 @default.
• W2783142536 cites W2017816559 @default.
• W2783142536 cites W2022072812 @default.
• W2783142536 cites W2025459290 @default.
• W2783142536 cites W2032740318 @default.
• W2783142536 cites W2036635542 @default.
• W2783142536 cites W2043993101 @default.
• W2783142536 cites W2050949125 @default.
• W2783142536 cites W2060070314 @default.
• W2783142536 cites W2082708772 @default.
• W2783142536 cites W2086766201 @default.
• W2783142536 cites W2090999266 @default.
• W2783142536 cites W2118102300 @default.
• W2783142536 cites W2120323942 @default.
• W2783142536 cites W2123023182 @default.
• W2783142536 cites W2130305562 @default.
• W2783142536 cites W2132923173 @default.
• W2783142536 cites W2132948331 @default.
• W2783142536 cites W2159717470 @default.
• W2783142536 cites W2184141705 @default.
• W2783142536 cites W2211884070 @default.
• W2783142536 cites W2220882815 @default.
• W2783142536 cites W2226317100 @default.
• W2783142536 cites W2236959863 @default.
• W2783142536 cites W2261810295 @default.
• W2783142536 cites W2266683146 @default.
• W2783142536 cites W2293998220 @default.
• W2783142536 cites W2295202170 @default.
• W2783142536 cites W2302088846 @default.
• W2783142536 cites W2307672716 @default.
• W2783142536 cites W2314057593 @default.
• W2783142536 cites W2341328097 @default.
• W2783142536 cites W2392630637 @default.
• W2783142536 cites W2395676613 @default.
• W2783142536 cites W2404234158 @default.
• W2783142536 cites W2413807845 @default.
• W2783142536 cites W2435830227 @default.
• W2783142536 cites W2485061009 @default.
• W2783142536 cites W2508324452 @default.
• W2783142536 cites W2508710837 @default.
• W2783142536 cites W2515679023 @default.
• W2783142536 cites W2521566919 @default.
• W2783142536 cites W2528617158 @default.
• W2783142536 cites W2529738115 @default.
• W2783142536 cites W2549999599 @default.
• W2783142536 cites W2556237894 @default.
• W2783142536 cites W2560431464 @default.
• W2783142536 cites W2560809537 @default.
• W2783142536 cites W2563590027 @default.
• W2783142536 cites W2565954919 @default.
• W2783142536 cites W2566818372 @default.
• W2783142536 cites W2567424265 @default.
• W2783142536 cites W2568340991 @default.
• W2783142536 cites W2589745780 @default.
• W2783142536 cites W2590377701 @default.
• W2783142536 cites W2595349270 @default.
• W2783142536 cites W2595403257 @default.
• W2783142536 cites W2599186117 @default.
• W2783142536 cites W2603665089 @default.
• W2783142536 cites W2604181632 @default.
• W2783142536 cites W2604901999 @default.
• W2783142536 cites W2606328008 @default.
• W2783142536 cites W2607471147 @default.
• W2783142536 cites W2610929033 @default.
• W2783142536 cites W2610980798 @default.
• W2783142536 cites W2614458325 @default.
• W2783142536 cites W2618202329 @default.
• W2783142536 cites W2618666290 @default.
• W2783142536 cites W2619867544 @default.
• W2783142536 cites W2621703330 @default.
• W2783142536 cites W2623937438 @default.
• W2783142536 cites W2624175890 @default.
• W2783142536 cites W2624443164 @default.
• W2783142536 cites W2625356082 @default.
• W2783142536 cites W2644550223 @default.
• W2783142536 cites W2652725838 @default.
• W2783142536 cites W2666875351 @default.
• W2783142536 cites W2674328052 @default.
• W2783142536 cites W2681369214 @default.
• W2783142536 cites W2688905162 @default.
• W2783142536 cites W2693846820 @default.
• W2783142536 cites W2693970509 @default.
• W2783142536 cites W2724264513 @default.

• next